Title: Advancements in Fluorescence Endoscopy for Early Detection of Colon Cancer

Early and accurate detection of gastrointestinal cancers necessitates innovative molecular probes and advanced imaging technologies. This article discusses the development of a wide-field fluorescence endoscopic device that integrates both fluorescence and white-light imaging capabilities to enhance the visualization of dysplastic and malignant tissues.

Innovative Imaging Technology

To achieve effective early detection, we adapted a clinical fiberscope for wide-field fluorescence imaging, allowing for comprehensive assessments at the point of care. The device utilizes a fluorescent probe, BMV109, which emits signals when cleaved and bound to active cathepsin proteases—enzymes significantly expressed in inflammation- and tumor-associated macrophages, as well as in certain tumor cells. The fiberscope’s compact design (1 mm in outer diameter) facilitates its use during endoscopic examinations in murine models, where we tested its efficacy in detecting colon polyps induced by azoxymethane.

Promising Results in Animal Models

The fluorescence imaging capabilities of our endoscopic device demonstrated clear localization of BMV109 to polypoid regions, distinguishing them from adjacent normal colon tissue with a significant p-value (p < 0.004). This sensitivity indicates the potential of the fiberscope to detect tumors at challenging locations, enhancing early diagnosis. The device was designed for use with small fluorescence microscopes, enabling both wide-field and microscopic examinations.

Addressing a Critical Need in Cancer Detection

Cancer remains a leading cause of mortality in the United States, with over 1.6 million new cases projected annually. Current diagnostic methods, including conventional endoscopy, often rely on white light, which can miss up to 25% of tumors. This limitation underscores the urgent need for advanced diagnostic tools that provide detailed molecular insights. Fluorescence endoscopy stands out as a promising solution, utilizing specific molecular probes to enable early detection of dysplastic or malignant tissues.

Technical Modifications and Adaptations

We modified a commercially available white-light fiberscope, which is FDA-approved for imaging bile ducts, to incorporate fluorescence capabilities. This adaptation allows for dual imaging modes—white light for structural assessment and fluorescence for functional analysis—using a dual-illumination setup. The system employs a 660-nm laser for fluorescence and a white-light LED for standard imaging, with a sensitive EMCCD camera for capturing fluorescence signals.

In Vivo Imaging and Experimental Design

The modified fiberscope was successfully introduced into the distal colon of mice, where we evaluated polyp characteristics. By employing a novel approach, we administered the BMV109 probe intrarectally, allowing for real-time imaging of tumor progression. This technique is particularly beneficial in transgenic and carcinogen-induced mouse models, where traditional imaging methods may fall short.

Results and Implications for Human Applications

Our trials revealed that the combination of the fluorescence fiberscope and BMV109 effectively detected colorectal tumors, even at early stages. Fluorescence imaging allowed for the identification of small polyps that would typically be missed during routine examinations. The fiberscope’s capability to visualize functional changes in tissues holds significant potential for enhancing early cancer detection in clinical settings.

Conclusion

The integration of fluorescence imaging into endoscopic diagnostics represents a substantial advancement in the fight against colon cancer. The use of targeted molecular probes like BMV109 coupled with innovative imaging technologies can significantly improve the detection rates of dysplastic lesions. As we refine these tools and explore their clinical translation, the potential to reduce cancer-related mortality through early detection becomes increasingly attainable.

Key Takeaways

• The development of a wide-field fluorescence endoscopic device enhances early detection of colon cancer.

• BMV109, a fluorescent probe, specifically targets active cathepsin proteases in tumors, providing clear imaging of polyps.

• The dual imaging capabilities of the modified fiberscope allow for comprehensive assessments of gastrointestinal tissues.

• Early detection through advanced imaging technologies can significantly impact patient outcomes and survival rates.

Read more → pmc.ncbi.nlm.nih.gov